Pharmaceutical Strategies for Stabilizing Drug Nanocrystals

Author(s): Hyerim Yang, Hyeongmin Kim, Sumin Jung, Hyeyeon Seo, Shofa Khoirun Nida, Seung-Yup Yoo, Jaehwi Lee*.

Journal Name: Current Pharmaceutical Design

Volume 24 , Issue 21 , 2018

Submit Manuscript
Submit Proposal

Abstract:

Background: Nanocrystallization technologies have been widely studied in recent years, as the formulation of drug nanocrystals solves problems of poor drug solubility and bioavailability. However, drug nanocrystals in the size range of 1–1000 nm usually need to be accompanied by stabilizers, such as polymers or surfactants, to enhance their stability. Despite their simplicity, improved dissolution rate, and enhanced bioavailability, the limited stability of nanocrystal formulations has prevented further development.

Objective: The most effective way to handle this instability is to use stabilizers. This paper reviews various factors to consider for the production of stable drug nanocrystals and provides suggestions to overcome the problems associated with instability, such as aggregation and Ostwald ripening. Through various examples of stabilizers acting via electrostatic and steric stabilization, this review highlights the scope of enhancing the stability of drug nanocrystals.

Conclusion: Studies on stabilizers used in the production of drug nanocrystals are ongoing; various factors, such as the effect of zeta potential on the stability of drug nanosuspensions, have already been revealed. However, it is necessary to determine the most appropriate stabilizer experimentally based on the various mechanisms and factors have been reviewed since the possible interactions between each drug and stabilizer are diverse.

Keywords: Drug nanocrystals, nanosuspension, stabilizers, stability, aggregation, polymers, surfactants.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 24
ISSUE: 21
Year: 2018
Page: [2362 - 2374]
Pages: 13
DOI: 10.2174/1381612824666180515125247
Price: $58

Article Metrics

PDF: 25
HTML: 6